SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • May 31st, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Exchange Agreement (this “Agreement”) is dated as of May 31, 2017, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each holder identified on the signature pages hereto (each, including its successors and assigns, a “Holder” and collectively the “Holders”).
